Debt-to-equity of Akoya Biosciences, Inc. from 30 Sep 2021 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Akoya Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Mar 2025.
  • Akoya Biosciences, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 1260%, a 478% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Akoya Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 1260% +1042% +478% 31 Mar 2025
Q4 2024 626% +421% +206% 31 Dec 2024
Q3 2024 398% +201% +102% 30 Sep 2024
Q2 2024 284% +103% +57% 30 Jun 2024
Q1 2024 218% +59% +37% 31 Mar 2024
Q4 2023 205% +86% +73% 31 Dec 2023
Q3 2023 197% +109% +125% 30 Sep 2023
Q2 2023 181% +115% +174% 30 Jun 2023
Q1 2023 159% +107% +206% 31 Mar 2023
Q4 2022 119% +46% +64% 31 Dec 2022
Q3 2022 88% -50% -37% 30 Sep 2022
Q2 2022 66% 30 Jun 2022
Q1 2022 52% 31 Mar 2022
Q4 2021 72% 31 Dec 2021
Q3 2021 138% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.